Artificial Intelligence Distinguishes Pathological Gait: The Analysis of Markerless Motion Capture Gait Data Acquired by an iOS Application (TDPT-GT).

Journal: Sensors (Basel, Switzerland)
PMID:

Abstract

Distinguishing pathological gait is challenging in neurology because of the difficulty of capturing total body movement and its analysis. We aimed to obtain a convenient recording with an iPhone and establish an algorithm based on deep learning. From May 2021 to November 2022 at Yamagata University Hospital, Shiga University, and Takahata Town, patients with idiopathic normal pressure hydrocephalus ( = 48), Parkinson's disease ( = 21), and other neuromuscular diseases ( = 45) comprised the pathological gait group ( = 114), and the control group consisted of 160 healthy volunteers. iPhone application TDPT-GT captured the subjects walking in a circular path of about 1 meter in diameter, a markerless motion capture system, with an iPhone camera, which generated the three-axis 30 frames per second (fps) relative coordinates of 27 body points. A light gradient boosting machine (Light GBM) with stratified k-fold cross-validation (k = 5) was applied for gait collection for about 1 min per person. The median ability model tested 200 frames of each person's data for its distinction capability, which resulted in the area under a curve of 0.719. The pathological gait captured by the iPhone could be distinguished by artificial intelligence.

Authors

  • Chifumi Iseki
    Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata 990-9585, Japan.
  • Tatsuya Hayasaka
    Department of Anesthesiology, Yamagata University School of Medicine, Yamagata 990-2331, Japan.
  • Hyota Yanagawa
    Department of Medicine, Yamagata University School of Medicine, Yamagata 990-2331, Japan.
  • Yuta Komoriya
    Department of Anesthesiology, Yamagata University School of Medicine, Yamagata 990-2331, Japan.
  • Toshiyuki Kondo
    Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata 990-9585, Japan.
  • Masayuki Hoshi
    Department of Physical Therapy, Fukushima Medical University School of Health Sciences, 10-6 Sakaemachi, Fukushima 960-8516, Japan.
  • Tadanori Fukami
  • Yoshiyuki Kobayashi
    Graduate School of Business Sciences, University of Tsukuba, Tokyo, Japan.
  • Shigeo Ueda
    Shin-Aikai Spine Center, Katano Hospital, Katano 576-0043, Japan.
  • Kaneyuki Kawamae
    Department of Anesthesia and Critical Care Medicine, Ohta-Nishinouti Hospital, Koriyama 963-8558, Japan.
  • Masatsune Ishikawa
    Normal Pressure Hydrocephalus Center, Rakuwakai Otowa Hospital, Kyoto 607-8062, Japan.
  • Shigeki Yamada
    Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Japan.
  • Yukihiko Aoyagi
    Digital Standard Co., Ltd., Osaka 536-0013, Japan.
  • Yasuyuki Ohta
    Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata 990-9585, Japan.